Suchen
LakeShore Biopharma Co Ltd
LSBZur Watchlist hinzufügen
0.627USD
0.0000.00%
Handelsschluss 07/02, 13:00（ET）Kurse um 15 Minuten verzögert
13.02MMarktkapitalisierung
--KGV TTM
mehr Informationen über LakeShore Biopharma Co Ltd Unternehmen
LakeShore Biopharma Co Ltd, formerly YS Biopharma Co Ltd, is a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. The Company's vaccine product YSJATM rabies vaccine has been commercialized. The Company also has four product candidates under various clinical development stages, including PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, PIKA YS-ON-001 and PIKA YS-HBV-001, and four preclinical stage product candidates, targeting HBV, influenza and cancer with enormous medical demand. In addition, the Company is working on a series of therapeutic targets, rabies and products at the discovery stage.
LakeShore Biopharma Co Ltd Informationen
BörsenkürzelLSB
Name des UnternehmensLakeShore Biopharma Co Ltd
IPO-datumJul 30, 2021
CEOMr. Dave Chenn
Anzahl der mitarbeiter573
WertpapierartOrdinary Share
GeschäftsjahresendeJul 30
AddresseBuilding No. 2, 38 Yongda Road
StadtBEIJING
BörseNASDAQ Capital Market Consolidated
LandChina
Postleitzahl102629
Telefon
Websitehttps://www.ysbiopharm.com/
BörsenkürzelLSB
IPO-datumJul 30, 2021
CEOMr. Dave Chenn
Führungskräfte von LakeShore Biopharma Co Ltd
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Yi Zhang
Mr. Yi Zhang
Chairman of the Board
Chairman of the Board
4.91M
--
Mr. Dave Chenn
Mr. Dave Chenn
Interim Co-Chief Executive Officer, Director
Interim Co-Chief Executive Officer, Director
462.76K
--
Dr. Hui (David) Shao
Dr. Hui (David) Shao
President, Co-Chief Executive Officer, Director, Chief Business Officer
President, Co-Chief Executive Officer, Director, Chief Business Officer
313.64K
--
Ms. Chunyuan Wu
Ms. Chunyuan Wu
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Zenaida Reynoso Mojares
Dr. Zenaida Reynoso Mojares
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Chunyang Shao
Mr. Chunyang Shao
Director
Director
--
--
Mr. Gang Li
Mr. Gang Li
Head of Marketing and sales
Head of Marketing and sales
--
--
Dr. Stanley Yi Chang
Dr. Stanley Yi Chang
Independent Director
Independent Director
--
--
Dr. Ajit Shetty
Dr. Ajit Shetty
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Thomas Xue
Mr. Thomas Xue
Director
Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Yi Zhang
Mr. Yi Zhang
Chairman of the Board
Chairman of the Board
4.91M
--
Mr. Dave Chenn
Mr. Dave Chenn
Interim Co-Chief Executive Officer, Director
Interim Co-Chief Executive Officer, Director
462.76K
--
Dr. Hui (David) Shao
Dr. Hui (David) Shao
President, Co-Chief Executive Officer, Director, Chief Business Officer
President, Co-Chief Executive Officer, Director, Chief Business Officer
313.64K
--
Ms. Chunyuan Wu
Ms. Chunyuan Wu
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Zenaida Reynoso Mojares
Dr. Zenaida Reynoso Mojares
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Chunyang Shao
Mr. Chunyang Shao
Director
Director
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von LakeShore Biopharma Co Ltd?
Die fünf größten Anteilseigner von LakeShore Biopharma Co Ltd sind: Mr. Yi Zhang
Wie viele Institutionen halten Anteile an LakeShore Biopharma Co Ltd (LSB)?
Mit Stand vom 2026Q1 halten 18 Institutionen Anteile an LakeShore Biopharma Co Ltd, mit einem Gesamtmarktwert von etwa 606.46K, was 1.47% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -1434782.00 gestiegen.